Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
These trade-offs can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you find high-quality companies that can grow their earnings no matter what. That said, here is one large-cap stock with attractive long-term potential and two whose existing offerings may be tapped out.
Two Large-Cap Stocks to Sell:
Moderna (MRNA)
Market Cap: $57.94 billion
Rising to global prominence during the COVID-19 pandemic with one of the first effective vaccines, Moderna (NASDAQ:MRNA) develops messenger RNA (mRNA) medicines that direct the body's cells to produce proteins with therapeutic or preventive benefits for various diseases.
Why Are We Out on MRNA?
- Annual sales declines of 20.5% for the past five years show its products and services struggled to connect with the market during this cycle
- Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 24.5% annually, worse than its revenue
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 95.9 percentage points
Moderna’s stock price of $145.83 implies a valuation ratio of 25.8x forward price-to-sales. Check out our free in-depth research report to learn more about why MRNA doesn’t pass our bar.
MSCI (MSCI)
Market Cap: $40.97 billion
Originally known as Morgan Stanley Capital International before becoming independent in 2007, MSCI (NYSE:MSCI) provides critical decision support tools, indexes, and analytics that help global investors understand risk and return factors and build more effective investment portfolios.
Why Does MSCI Fall Short?
- Negative return on equity shows management lost money while trying to expand the business
At $564.21 per share, MSCI trades at 26.9x forward P/E. Dive into our free research report to see why there are better opportunities than MSCI.
One Large-Cap Stock to Buy:
Comfort Systems (FIX)
Market Cap: $58.17 billion
Formed through the merger of 12 companies, Comfort Systems (NYSE:FIX) provides mechanical and electrical contracting services.
What Makes FIX Stand Out?
- Average backlog growth of 56% over the past two years shows it has a steady sales pipeline that will drive future orders
- Free cash flow margin jumped by 15.1 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Improving returns on capital reflect management’s ability to monetize investments
Comfort Systems is trading at $1,660 per share, or 31.4x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.